Sensor maker AMS expects limited second-quarter impact from coronavirus
Sensor specialist AMS expects the impact from the new coronavirus in the second quarter to be limited, it said on Wednesday after reporting first-quarter revenues...
Trump hails U.S. coronavirus testing as infections cross a million
The United States has reported more than a million coronavirus infections only because of its testing, President Donald Trump said on Wednesday, hailing the effort...
AstraZeneca beats first-quarter profit estimates, retains 2020 forecast
AstraZeneca on Wednesday beat analysts’ estimates for first-quarter profit and reiterated its outlook for 2020, as demand for the company’s newer medicines remained steady....
Next sales slump after stores shuttered in coronavirus lockdown
British clothing retailer Next said on Wednesday total product sales in its latest quarter crashed 41%, reflecting the closure of all its stores in the...
Asia shares hit seven-week high, oil rallies as economies slowly re-open
Asian shares climbed to a near two-month peak on Wednesday as investors took heart from easing coronavirus lockdowns in some parts of the world, better-than-expected...
StanChart eyes quick recovery as profit falls 12% on coronavirus crisis
Standard Chartered PLC on Wednesday said it expects virus-battered economies to recover later this year, striking an optimistic note after increased credit impairment and provisions...
AirAsia will not take jet deliveries this year, re-looking at Airbus order book
Malaysia’s AirAsia Group Bhd said on Wednesday it did not intend to take any new aircraft deliveries this year due to the sharp fall in...
WPP says COVID-19 dragged March net sales down 7.9%, braces for bigger impact
WPP , the world’s biggest advertising company, said net sales fell 3.3% in the first quarter, with the impact of the COVID-19 pandemic dragging it...
Murray says resuming season stalled by pandemic not top priority
Resuming the tennis season stalled by the coronavirus pandemic is not the most important thing as players first want to live their normal lives again,...
Novartis wins expanded European OK for Cosentyx amid pursuit of $5 billion sales
Novartis on Wednesday won a new European approval for its inflammation drug Cosentyx in a form of arthritis, as the Swiss drugmaker predicts broadening use...
